Brokerages Set DRI Healthcare Trust (TSE:DHT.UN) PT at C$18.00

DRI Healthcare Trust (TSE:DHT.UN) has earned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is C$18.00.

A number of brokerages recently commented on DHT.UN. Raymond James lowered their target price on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th. Scotiabank lifted their price target on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th.

DRI Healthcare Trust Trading Up 48.9 %

Shares of DHT.UN opened at C$12.95 on Thursday. The stock has a 50-day simple moving average of C$13.41 and a 200-day simple moving average of C$13.37. DRI Healthcare Trust has a 1 year low of C$10.39 and a 1 year high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were given a $0.085 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a yield of 2.63%. DRI Healthcare Trust’s dividend payout ratio (DPR) is presently -920.00%.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.